Author

Andre Navarro

University of Colorado AnschutzORCID 0000-0002-7360-3369Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1

Frequent Co-Authors

Raphael A. NemenoffiD· 3 shared Abby AstiD· 1 shared Allison DubneriD· 1 shared Amber M. Johnson· 1 shared Anh T. Le· 1 shared Austin JollyiD· 1 shared D. Ross CamidgeiD· 1 shared Daniel SkhisoviD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Raphael A. NemenoffORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting wild type NTRK decreases brain metastases of lung cancers non-driven by NTRK fusions

Maria Jose Contreras-Zarate, Jenny A. Jaramillo-Gómez, Ricaurte Alejandro Marquez-Ortíz, Trinh C. Pham, Stella N. Koliavas, David Ryan Ormond, Andre Navarro, Raphael A. Nemenoff, D. Ross Camidge, Diana M. Cittelly

This study shows that NTRK inhibitors can reduce brain metastases in lung cancers with wild-type NTRK, even without NTRK fusions.

Cancer Research Communications · Jul 21, 2026Peer-reviewedCancer Biology

Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma

Trista K. Hinz, Anh T. Le, Tristan Doan, Abby Ast, Sophia Jaramillo, Jasalyn T. Avila, Daniel Skhisov, Samantha Haines, Andre Navarro, Tejas Patil, Raphael A. Nemenoff, Lynn E. Heasley

This study models acquired resistance to RET inhibitors in murine lung cancer and identifies combination therapies that improve treatment outcomes.

Cancer Letters · Mar 31, 2026Peer-reviewedCancer Biology

Klf4-dependent pivotal role of smooth muscle-derived Gli1+ lineage progenitor cells in lung cancer progression

Sizhao Lu, Andre Navarro, Amber M. Johnson, Tysen Noble, Austin Jolly, Allison Dubner, Karen S. Moulton, Raphael A. Nemenoff, Mary C. M. Weiser-Evans

This study identifies AdvSca1-SM cells as a key component of lung tumors and shows that Klf4-dependent regulation of these cells affects cancer progression and immunotherapy response.

bioRxiv · May 30, 2025 · PreprintCancer Biology